文献速递临床试验与 GCP流行病学与生物统计

血管内治疗后头部体位对急性大血管闭塞性卒中功能结局的影响:HeadSOAR多中心随机对照试验

Head positioning after endovascular therapy for acute stroke due to large vessel occlusion (HeadSOAR): multicentre randomised controlled trial.
PubMed 文献 · BMJ · 2026-08-20

HeadSOAR试验在中国67家卒中中心纳入1368例前循环大血管闭塞且血管内取栓成功再灌注的急性缺血性卒中患者,随机分为抬高床头30-40°组与平卧0-10°组并维持72小时。结果显示抬高床头未显著改善90天功能结局(调整广义优势比1.12,95%CI 0.97-1.29,P=0.14),90天全因死亡率亦无显著差异(调整风险比0.86,95%CI 0.69-1.07,P=0.18)。

要点

  • 取栓成功再灌注后72小时抬高床头30-40°未显著改善90天功能结局。
  • 抬高床头组90天全因死亡率18.3%,平卧组20.3%,差异无统计学意义。
  • 两组间较小的效应差异提示抬高床头可能存在适度临床获益,尚需进一步研究。

核心结论

  • 对于前循环大血管闭塞经血管内取栓成功再灌注的急性缺血性卒中患者,72小时抬高床头30-40°较平卧0-10°未显著改善90天功能结局。
  • 90天全因死亡率在两组间无显著差异。
  • 两组结果差异小于预期,不能排除抬高床头存在适度但有临床意义的获益可能。

研究设计与样本

  • 多中心、前瞻性、随机、开放标签、盲法终点临床试验。
  • 中国67家综合卒中中心参与,招募时间为2023年11月16日至2025年1月23日。
  • 共随机1368例成人(年龄≥18岁)前循环大血管闭塞急性缺血性卒中患者,取栓后eTICI评分≥2b定义为成功再灌注。
  • 按1:1随机分为抬高床头30-40°组(n=685)和平卧0-10°组(n=683),干预持续72小时。
  • 主要结局为随机后90天mRS评分(范围0-6)的移位分析;主要安全结局为随机后90天全因死亡率。

主要发现

  • 1368例随机患者中位年龄68岁,女性565例(41.3%),1358例(99.3%)完成90天随访。
  • 基线NIHSS评分中位数15分。
  • 90天mRS评分中位数两组均为3分(IQR 1-5);调整广义优势比1.12(95%CI 0.97-1.29,P=0.14)。
  • 90天全因死亡率:抬高床头组125/682例(18.3%),平卧组137/676例(20.3%);调整风险比0.86(95%CI 0.69-1.07,P=0.18)。

关键数值与推荐

  • 纳入标准:年龄≥18岁,前循环大血管闭塞急性缺血性卒中,血管内取栓后eTICI≥2b。
  • 干预措施:取栓后72小时内维持抬高床头30-40°或平卧0-10°。
  • 主要结局评估:90天mRS评分移位分析。
  • 主要安全结局:90天全因死亡率。
  • 调整模型纳入年龄、基线NIHSS评分、基线ASPECTS、闭塞部位及从最后已知良好时间到随机化的时间。

临床怎么用

  • 对于取栓成功再灌注的前循环大血管闭塞卒中患者,抬高床头30-40°未显示显著功能获益,临床决策可个体化考虑。
  • 抬高床头30-40°未增加90天死亡风险,安全性可接受。
  • 鉴于效应差异小于预期,抬高床头可能存在适度临床获益,需结合患者具体情况权衡。

局限性

  • 开放标签设计,尽管终点评估采用盲法,仍可能存在偏倚。
  • 两组结果差异小于预期,研究可能不足以检出适度但临床有意义的获益。
  • 干预仅持续72小时,更长时程的体位影响未评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To determine whether an elevated head position (30-40°) improves functional outcomes compared with a flat head position (0-10°) in patients with acute ischaemic stroke caused by anterior circulation large vessel occlusion who have achieved successful reperfusion after endovascular thrombectomy. DESIGN: Multicentre, prospective, randomised, open label, blinded endpoint clinical trial. SETTING: 67 comprehensive stroke centres in China, between 16 November 2023 and 23 January 2025. PARTICIPANTS: 1368 adults (aged ≥18 years) with acute ischaemic stroke caused by anterior circulation large vessel occlusion who achieved successful endovascular reperfusion, defined as an expanded thrombolysis in cerebral infarction score ≥2b after endovascular thrombectomy. INTERVENTIONS: Participants were randomly assigned (1:1) to maintain either an elevated head position (30-40°, n=685) or a flat head position (0-10°, n=683) for 72 hours after endovascular thrombectomy. MAIN: outcome measures The primary outcome was functional status at 90 days after randomisation, assessed by shift analysis of scores on the modified Rankin scale (range 0-6). The primary safety outcome was all cause mortality at 90 days after randomisation. Efficacy analyses used the randomised, full analysis set, and safety analyses used the safety population (identical to the randomised population). Adjusted models included age, baseline National Institutes of Health Stroke Scale score (NIHSS), baseline Alberta Stroke Programme Early Computed Tomography Score, occlusion site, and time from last known well (ie, the last time when the patient was known to be at their usual neurological baseline before the current stroke event) to randomisation. RESULTS: In the population of 1368 randomised patients, the median age was 68 years, 565 participants (41.3%) were women, and 1358 (99.3%) completed the 90 day follow-up. The median baseline NIHSS score was 15, the median 90 day modified Rankin scale score was 3 (interquartile range (IQR) 1-5) in the head elevation group versus 3 (IQR 1-5) in the flat head position group (adjusted generalised odds ratio for a lower level of disability 1.12, 95% confidence interval (CI) 0.97 to 1.29, P=0.14). All cause mortality at 90 days occurred in 125 (18.3%) of 682 patients in the elevated head position group and 137 (20.3%) of 676 patients in the flat head position group (adjusted risk ratio 0.86, 95% CI 0.69 to 1.07, P=0.18). CONCLUSIONS: 72 hours of head elevation did not significantly improve 90 day functional outcomes versus flat head positioning in patients who had acute ischaemic stroke from large vessel occlusion with successful reperfusion after thrombectomy. The smaller than expected difference in results between the two groups leaves open the possibility of a modest but clinically meaningful benefit of head elevation in these patients. TRIAL: registration ClinicalTrials.gov NCT06115707.

来源:BMJ,查看原文。版权归原作者所有。

引用

  1. Yuan Z, Peng J, Gu L, et al. Head positioning after endovascular therapy for acute stroke due to large vessel occlusion (HeadSOAR): multicentre randomised controlled trial. BMJ. 2026. PMID: 42624516. doi:10.1136/bmj-2026-100363

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。